Juvenescence and the Buck Institute launch Selah Therapeutics, targeting heart disease
Juvenescence & the Buck Institute announce a new joint venture with the formation of Selah Therapeutics Limited (“Selah”). Selah focuses on developing ketone-based therapies to treat heart failure & other...